In the next 5 years, the market is expected to grow to $105 billion, representing a 17.5x increase in market value: By 2030, the US GLP-1 patient pool will include 15 million people, representing 9% of Americans with diet-related diseases
Barimelts GLP-1 Journey Pack is designed to address the unique challenges bariatric patients and GLP-1 users face
Cycles run 8-12 weeks on, 4 weeks off
Step 2 Customized Dosing: Tailored to your needs, comfort level, and treatment response
These additional compounds each require independent calculation, expanding the planning needed but not changing the fundamental math for any single peptide
Present and future challenges in food analysis: Foodomics